The total return over the past 12 months is -65.00% vs. +16.94% for the S&P 500. So far it's up -20.72% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (65.00%) | (36.46%) | (52.81%) | N/A | N/A | N/A |
| Total Return CAGR | (65.00%) | (36.46%) | (52.81%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Tenaya Therapeutics, Inc. (TNYA)
| Year | Start price | End price | TNYA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $0.71 | $0.56 | (20.72%) | +14.51% | (35.23%) |
| 2025 | $1.43 | $0.71 | (50.24%) | +17.72% | (67.96%) |
| 2024 | $3.24 | $1.43 | (55.86%) | +24.89% | (80.75%) |
| 2023 | $2.01 | $3.24 | +61.19% | +26.19% | +35.00% |
| 2022 | $18.95 | $2.01 | (89.39%) | (18.17%) | (71.22%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
